MedPath

Study comparing intravenous Dexmedetomidine and intravenous Dexmedetomidine for attenuation of hemodynamic responses on laryngoscopy, intubation and skull pin application during open brain surgery

Phase 4
Not yet recruiting
Conditions
Other disorders of central nervoussystem,
Registration Number
CTRI/2021/08/035835
Lead Sponsor
King George Mrdical University
Brief Summary

This study will compare Intravenous dexmedetomidine with intranasal dexmedetomidine for attenuation of hemodynamic response to laryngoscopy, intubation and fixation of skull pin holder in patient undergoing elective craniotomy

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patient belonging to ASA 1and 2 Patient belongings to age 18 to 70 years Patient giving informed and written consent.

Exclusion Criteria

Patient with known allergy or hypersensitivity to dexmedetomidine Patient with history of ischemic heart disease, second or third degree heart block, head injury, uncontrolled hypertension, uncontrolled diabetes, pregnancy,and previous craniotomy incision Patient with respiratory disease and predicted difficult airway Patient who refuse to give consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare mean arterial pressureBaseline 5 min after, 10 min after after drug administration before laryngosopy and intubation, at 1 min, 3 min, 5 min after intubation,before pin insertion at 1min, 5 min, 10 min,20 min,30 min,60 min afterpin insertion,sedation status at baseline and 10 min after drug administration
Secondary Outcome Measures
NameTimeMethod
To compare systolic and diastolic blood pressure along with sedation score and adverse effectsBaseline 5 min after, 10 min after after drug administration before laryngosopy and intubation, at 1 min, 3 min, 5 min after intubation,before pin insertion at 1min, 5 min, 10 min,20 min,30 min,60 min afterpin insertion,sedation status at baseline and 10 min after drug administration

Trial Locations

Locations (1)

Kgmu

🇮🇳

Lucknow, UTTAR PRADESH, India

Kgmu
🇮🇳Lucknow, UTTAR PRADESH, India
Garima
Principal investigator
9956886567
garimasinghetw@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.